| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | 1 | — | — | — | — | — | — |
| Sell | — | — | — | — | 1 | 1 | — | — | — | — | 2 | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 0.80 |
—
—
—
|
| 2025 | 0.80 |
—
—
—
—
|
| 2024 | 0.80 |
—
—
—
—
|
| 2023 | 90.80 |
—
—
—
—
—
|
| 2022 | 270.80 |
—
—
—
—
—
—
—
|
| 2021 | 360.70 |
—
—
—
—
—
—
—
—
|
| 2020 | 320.60 |
—
—
—
—
—
—
—
—
|
| 2019 | 240.55 |
—
—
—
—
—
—
—
|
| 2018 | 320.40 |
—
—
—
—
—
—
—
—
|
| 2017 | 0.37 |
—
—
—
—
|
| 2016 | 0.26 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 695.00 | 885.00 | 1,212.00 | 491.00 |
| Receivables | 2,057.00 | 2,166.00 | 2,606.00 | 3,262.00 |
| Inventory | 1,531.00 | 1,477.00 | 2,013.00 | 2,517.00 |
| Other | 600.00 | 313.00 | 282.00 | 381.00 |
| 4,883.00 | 4,841.00 | 6,113.00 | 6,651.00 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 3,661.00 | 3,418.00 | 4,452.00 | 4,549.00 |
| ST’ Debt | 1,065.00 | 361.00 | 21.00 | 692.00 |
| Other | 1,214.00 | 765.00 | 711.00 | 744.00 |
| 6,185.00 | 4,847.00 | 5,487.00 | 6,221.00 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 3,603.00 | 3,997.00 | — | — |
—
|
| ’25 | 3,097.00 | 3,338.00 | 3,379.00 | 3,347.00 |
13,161.00
|
| ’24 | 2,874.00 | 2,959.00 | 3,082.00 | 2,880.00 |
11,795.00
|
| ’23 | 2,981.00 | 3,067.00 | 3,111.00 | 2,903.00 |
12,062.00
|
| ’22 | 3,716.00 | 4,134.00 | 3,951.00 | 1,571.00 |
13,372.00
|
| ’21 | 3,125.00 | 3,459.00 | 3,553.00 | 3,674.00 |
13,811.00
|
| ’20 | 2,785.00 | 2,801.00 | 3,093.00 | 3,102.00 |
11,781.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (777.00) | 608.00 | — | — |
—
|
| ’25 | (665.00) | 332.00 | 384.00 | 1,211.00 |
1,262.00
|
| ’24 | (1,247.00) | 252.00 | 610.00 | 500.00 |
115.00
|
| ’23 | (275.00) | 636.00 | 766.00 | 736.00 |
1,863.00
|
| ’22 | (804.00) | 406.00 | 174.00 | 525.00 |
301.00
|
| ’21 | (477.00) | 645.00 | 708.00 | 884.00 |
1,760.00
|
| ’20 | (708.00) | 476.00 | 577.00 | 1,087.00 |
1,432.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (938.00) | 467.00 | — | — |
—
|
| ’25 | (746.00) | 236.00 | 257.00 | 1,041.00 |
788.00
|
| ’24 | (1,401.00) | 146.00 | 493.00 | 393.00 |
(369.00)
|
| ’23 | (618.00) | 371.00 | 544.00 | 521.00 |
818.00
|
| ’22 | (1,166.00) | (51.00) | (269.00) | 136.00 |
(1,350.00)
|
| ’21 | (840.00) | 251.00 | 261.00 | 362.00 |
34.00
|
| ’20 | (921.00) | 242.00 | 341.00 | 657.00 |
319.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.77 | 0.83 | — | — |
—
|
| ’25 | 0.63 | 0.76 | 1.18 | 0.75 |
3.30
|
| ’24 | 11.61 | 0.51 | 0.65 | (0.11) |
13.00
|
| ’23 | 0.56 | 0.55 | 0.64 | 0.49 |
2.23
|
| ’22 | 1.37 | (0.55) | 1.24 | 0.17 |
2.25
|
| ’21 | 0.60 | 0.61 | 0.54 | 0.90 |
2.65
|
| ’20 | 0.07 | 0.28 | 0.72 | 0.68 |
1.76
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 46.00 | 42.81 | 54.06 | 43.51 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 97.99 | 62.14 | 71.32 | 60.29 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 21,000 | 21,000 | 16,000 | 16,000 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.64 | 0.57 | 0.74 | 0.82 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13,372.00 | 12,062.00 | 11,795.00 | 13,161.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 16.83% | 19.13% | 20.70% | 19.59% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 713.00 | 614.00 | 535.00 | 1,128.00 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.33% | 5.09% | 4.54% | 8.57% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 732.00 | 711.00 | 4,014.00 | 915.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 672.00 | 686.00 | 620.00 | 622.00 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 42.26 | 38.32 | 38.61 | 47.99 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 2.27 | 2.25 | 13.12 | 3.33 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.95 | 5.92 | 0.38 | 4.60 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (5.22) | (3.32) | (1.58) | (1.73) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (4.27) | 2.60 | (1.21) | 2.87 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.15 | 12.19 | 19.41 | 19.77 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 316.43 | 314.78 | 305.46 | 274.26 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 22.89 | 25.44 | 4.32 | 15.91 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.23 | 1.49 | 1.43 | 1.10 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.66 | 4.67 | 2.84 | 2.68 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.86 | 2.14 | 1.83 | 1.54 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (18.40) | 31.55 | (58.61) | 25.80 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 301.00 | 1,863.00 | 115.00 | 1,262.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1,651.00) | (1,045.00) | (484.00) | (474.00) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1,350.00) | 818.00 | (369.00) | 788.00 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1,519.00) | (1,302.00) | (6.00) | 626.00 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8,948.00 | 8,569.00 | 5,673.00 | 7,012.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8,400.00 | 7,874.00 | 4,788.00 | 5,800.00 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,527.00 | 3,837.00 | 5,930.00 | 5,421.00 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.63% | 3.61% | 21.71% | 4.91% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.40% | 5.54% | 4.45% | 7.97% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19.94% | 19.20% | 82.07% | 16.07% | — | — | — |
ROE
|
Ball Corporation (BALL), a leader in sustainable aluminum beverage packaging with ~60% North American market share, has shown resilience through cyclical pressures via strategic pivots: the 2016 Rexam acquisition doubled revenue to cement global dominance, while the 2024 $5.6 billion aerospace divestiture slashed debt 34% to $5.67 billion, boosted equity 55%, and refocused on core operations. Revenue peaked at $13.81 billion in 2021 amid pandemic-driven demand but contracted to $11.80 billion in 2024; analysts project a rebound to $13.16 billion in 2025 (+12% YoY) and 6% CAGR through 2027, fueled by capacity expansions and sustainability trends like 70% recyclable cans.
Efficiency gains shine through: revenue per employee rose 50% to $737,000 by 2024 despite a 34% workforce cut, with gross margins rebounding to 20.7% and EBT margins eyeing 8.6% in 2025. Normalized EPS is forecast to grow from $3.54 in 2026 to $4.06 in 2027 (15%+), supported by easing capex and positive FCF trends. Valuation looks compelling—forward PE at 19-22x below 10-year averages of 35x, PS at 1.1-1.4x, trading 6% below consensus targets with 15% upside potential versus 11% downside.
This setup implies 10-15% returns on execution amid aluminum tailwinds, though insider sells and raw material risks warrant caution. Ball’s moat in premium, eco-packaging positions it for mid-teens ROE normalization—read the full analysis for detailed models and probabilities.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.